CARDIAC STRUCTURE AND FUNCTION AND CHADS2 RISK SCORE IN PATIENTS WITH ATRIAL FIBRILLATION: THE EFFECTS ANTICOAGULATION WITH FACTOR XA NEXT GENERATION IN AFTHROMBOLYSIS IN MYOCARDIAL INFARCTION 48 (ENGAGE AF -TIMI 48) ECHOCARDIOGRAPHIC STUDY

CARDIAC STRUCTURE AND FUNCTION AND CHADS2 RISK SCORE IN PATIENTS WITH ATRIAL FIBRILLATION: THE EFFECTS ANTICOAGULATION WITH FACTOR XA NEXT GENERATION IN AFTHROMBOLYSIS IN MYOCARDIAL INFARCTION 48 (ENGAGE AF -TIMI 48) ECHOCARDIOGRAPHIC STUDY

Parameter N = 475 (49%) N = 283 (29%) N = 213 (22%) *P Age, years 70 (63-77) 75 (67-80) 76 (70-80) n/a LV ejection fraction, % 58.9 (54.2-60.8) 58.7 (48.4-60.3) 58.2 (53.8-60.8) 0.86 LV End Diastolic Diameter, cm 4.6 (4.4-4.9) 4.7 (4.4-4.9) 4.6 (4.3-4.8) 0.56 LV mass, g 137 (114-165) 134 (115-173) 1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2013-03, Vol.61 (10), p.E964-E964
Hauptverfasser: Gupta, Deepak K, Shah, Amil, Giugliano, Robert, Ruff, Christian, Antman, Elliott, Grip, Laura T, Deenadayalu, Naveen, Hoffman, Elaine, Betcher, Joshua, Patel, Indravadan, Shi, Minggao, Braunwald, Eugene, Solomon, Scott
Format: Artikel
Sprache:eng
Schlagworte:
Cardiac arrhythmia
Cardiology
Cardiovascular
Drug therapy
Heart attacks
Internal Medicine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Parameter N = 475 (49%) N = 283 (29%) N = 213 (22%) *P Age, years 70 (63-77) 75 (67-80) 76 (70-80) n/a LV ejection fraction, % 58.9 (54.2-60.8) 58.7 (48.4-60.3) 58.2 (53.8-60.8) 0.86 LV End Diastolic Diameter, cm 4.6 (4.4-4.9) 4.7 (4.4-4.9) 4.6 (4.3-4.8) 0.56 LV mass, g 137 (114-165) 134 (115-173) 145 (110-184) 0.22 e' avg, cm/s 7.8 (6.4-9.3) 7.6 (6.1-9.2) 7.2 (6.0-8.6)
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(13)60964-X